Clinical Trial Update: Olanzapine Treatment of Patients With Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating olanzapine for bipolar I disorder has completed, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder

Drugs mentioned

• Zyprexa (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Depression, Bipolar | Phase 3 | Status: COMPLETED | Results posted: 2011-05-26